Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Cambridge Cognition Holdings Plc
  6. News
  7. Summary
    COG   GB00B8DV9647

CAMBRIDGE COGNITION HOLDINGS PLC

(COG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Cambridge Cognition : to join the Brain Health Registry as cognitive assessment partner

06/11/2021 | 09:10am EDT

One of the key barriers facing treatment development for neurological and psychiatric conditions is difficulty recruiting the right patients into clinical trials and identifying these individuals at the very early stages of disease progression. In efforts to address this issue researchers at UCSF established the Brain Health Registry: an online enrolment platform for adults who are interested in participating in brain research.

Adults aged 18+ years who are interested in participating in research studies can enrol in the Brain Health Registry through the website: https://my.brainhealthregistry.org/BHR/register.

This secure, online platform is then used to deliver baseline questions on health, lifestyle and medical history. To build a full and sustained picture of function over an individual's lifespan, participants are also asked to complete web-based questionnaires and cognitive assessments every 6 months: including the CANTABTM Paired Associates Learning task.

By regularly assessing healthy adults the Brain Health Registry is building a unique and important resource on functional change over time. This data will be used to identify potential candidates for clinical trials and establish novel biomarkers to detect early stages of brain disorders. This could be beneficial for Cambridge Cognition in providing more real-world data on the use of the assessment and potentially a cohort of patients already assessed with a CANTAB™ test that could be used for a clinical trial.

For further information on the Brain Health Registry visit: https://www.brainhealthregistry.org/

Prof Michael Weiner, Lead Scientific Investigator at the Brain Health Registry, said:

'Accurate cognitive assessment is essential for the online Brain Health Registry to achieve its intended purpose: speeding up the discovery of effective treatments for brain disorders. Cambridge Cognition is joining us as a cognitive assessment partner helping us to speed up the discovery of effective treatments for brain disorders with their validated computerized cognitive assessments.'

Matthew Stork, Chief Executive Officer of Cambridge Cognition, said:

'One of the key challenges facing drug development is identifying which patients are most likely to benefit from a therapeutic intervention. The Brain Health Registry set up a web-based solution to tackle this issue: an online platform to longitudinally monitor adults who are interested in participating in research. The goal of our partnership is to assist the Brain Health Registry in bringing effective treatments for brain disorders by using our cognitive assessments.'

Disclaimer

Cambridge Cognition Holdings plc published this content on 11 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 June 2021 13:09:04 UTC.


© Publicnow 2021
All news about CAMBRIDGE COGNITION HOLDINGS PLC
06/11CAMBRIDGE COGNITION  : to join the Brain Health Registry as cognitive assessment..
PU
04/21COGNITION AND COVID-19 : CANTAB Research Grant - Results
PU
04/07CAMBRIDGE COGNITION  : provides cognitive assessments in an at-home clinical tri..
PU
03/30CAMBRIDGE COGNITION  : Lands $1.7 Million Contract for Schizophrenia Trial; Shar..
MT
01/19CAMBRIDGE COGNITION  : CFO Resigns
MT
01/19CAMBRIDGE COGNITION  : Stock Climbs 10% as 2020 Loss Shrinks, Revenue Soars 34%
MT
2020CAMBRIDGE COGNITION  : New virtual study to measure stress recovery in frontline..
PU
2020CAMBRIDGE COGNITION  : announces further contract wins in the first half of 2020
PU
2020CAMBRIDGE COGNITION  : Trading Update
PU
2020CAMBRIDGE COGNITION  : Grant of Options
PU
More news
Financials
Sales 2021 8,50 M 12,0 M 12,0 M
Net income 2021 0,10 M 0,14 M 0,14 M
Net cash 2021 2,20 M 3,10 M 3,10 M
P/E ratio 2021 467x
Yield 2021 -
Capitalization 43,5 M 61,3 M 61,3 M
EV / Sales 2021 4,86x
EV / Sales 2022
Nbr of Employees 58
Free-Float 58,4%
Chart CAMBRIDGE COGNITION HOLDINGS PLC
Duration : Period :
Cambridge Cognition Holdings Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CAMBRIDGE COGNITION HOLDINGS PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 1
Average target price 125,00 GBX
Last Close Price 140,00 GBX
Spread / Highest target -10,7%
Spread / Average Target -10,7%
Spread / Lowest Target -10,7%
EPS Revisions
Managers and Directors
NameTitle
Matthew William Stork Director, Chief Executive & Operating Officer
Michael Damien Holton Chief Financial Officer & Executive Director
Steven John Powell Chairman
Debra Leeves Non-Executive Director
Richard Edward Bungay Non-Executive Director